BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

5 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [ยน8F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.EBI
University Medical Center Groningen
Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.EBI
Universidad Ceu San Pablo
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.EBI
Pfizer
Reverse hydroxamate-based selective TACE inhibitors.EBI
Kaken Pharmaceutical
Pyridone derivative, pharmaceutical containing the same and methods of use thereofBDB
Kaken Pharmaceutical